Partially Neutralized Polyacrylate Pharma Grade API for Tablet / Capsule / Granule / Injection, Oral & Injectable, designated PNP-PG-45, is a low-crosslink sodium salt of polyacrylic acid with a degree of neutralization specified at 20–40 mol% relative to total carboxylic acid residues. The model designation PNP-PG-45 identifies the standard oral and injectable grade; a lower-neutralization variant PNP-PG-45L is available for direct compression with moisture-sensitive actives, and a higher-neutralization variant PNP-PG-45H is used where faster aqueous dispersion is required. The weight-average molecular weight is 250,000–600,000 g/mol by size-exclusion chromatography with multi-angle light scattering, with polydispersity index ≤2.5. The material is released as a spray-dried powder with particle size D₉₀ ≤150 µm by ISO 13320, bulk density 0.24–0.38 g/cm³ by USP <616> Method I, and residual acrylic acid monomer ≤0.25% w/w by Ph. Eur. 2.2.29 reversed-phase HPLC. The pH of a 0.5% w/v aqueous dispersion at 25 °C is 4.5–6.5 by Ph. Eur. 2.2.3, and the viscosity of a neutralized 0.5% w/v dispersion at pH 7.3–7.8 is 4,000–15,000 mPa·s using a Brookfield RVT, spindle 7, at 20 rpm per Ph. Eur. 2.2.10. Loss on drying is ≤5.0% w/w by USP <731>, and total aerobic microbial count is ≤100 CFU/g by USP <61>. For injectable applications, the release specification additionally requires bacterial endotoxins below 0.25 EU/mg by Ph. Eur. 2.6.14 and absence of visible particulate matter after reconstitution through a 5 µm clarifying filter. The partial neutralization distinguishes PNP-PG-45 from both non-neutralized polyacrylic acid and fully neutralized sodium polyacrylate: the residual acid fraction retains sufficient hydrogen-bonding capacity to limit cold-water gel blocking, while the sodium fraction permits direct dispersion without the pH excursion associated with in situ alkali addition. The low crosslink density is controlled by an allyl crosslinker level below 0.3% w/w; this value is stated in the product dossier rather than a public monograph.

The release specification matrix is assembled below to separate oral and injectable requirements.

What limits the degree of neutralization in a direct-compression binder?

Direct compression on a 16-station rotary tablet press with 8 mm concave tooling at 50 rpm defined the upper neutralization boundary as a moisture-dependent sticking limit rather than a compressional failure. At 35–40 mol% neutralization, ejection force remained below 450 N when magnesium stearate was present at 0.5% w/w and blended for 5 min; however, when the same formulation was stored at 60% RH for 24 h, tablet weight variability increased to ±3.0% RSD because the surface carboxylate layer adsorbed atmospheric moisture. Pre-drying at 40 °C for 12 h and addition of 0.2% w/w colloidal silicon dioxide restored powder flow to a Hausner ratio of 1.15 and a Carr index of 13%. A 5% w/w polymer level in microcrystalline cellulose 102 produced tablet hardness of 120 N crush force and friability of 0.6% after 100 rotations by USP <1216>. Disintegration time was 9–14 min by USP <701> when no disintegrant was present, confirming that the polymer acts as a moderately water-uptaking binder rather than as a superdisintegrant.

At neutralization below 20 mol%, the powder remains free-flowing at 60% RH but the aqueous dispersion pH falls below 4.0, which can impair acid-labile actives and increase corrosion risk on stainless steel contact surfaces. At neutralization above 40 mol%, the equilibrium moisture content under the same condition approaches 14% w/w, and caking in a 316L stainless steel drum was observed within 48 h unless desiccant was replaced at 24 h intervals. The operational window of 20–40 mol% therefore balances three competing constraints: dissolution pH, hygroscopicity, and tablet hardness.

Wet granulation with PNP-PG-45 at 2–5% w/w in purified water produces binder solution pH 5.0–6.0 and avoids local acid pockets observed when non-neutralized carbomer is dry-blended. Fluid-bed granulation at inlet air temperature 60 °C and product temperature 28–32 °C yielded granules with final moisture 1.5–2.5% w/w and D₅₀ 120–180 µm. On a high-shear granulator, impeller speeds above 300 rpm for more than 10 min generated viscous heating and over-wetted agglomerates when binder level exceeded 4% w/w; the affected batch could be recovered only by wet milling through a 1.0 mm screen and re-drying. Capsule filling on a dosator machine at 60,000 capsules/h was stable at fill weights from 100 mg to 500 mg when granules had Hausner ratio 1.10–1.25. Batch-to-batch variation in degree of neutralization was ±1.5 mol% across three commercial campaigns; this controlled viscosity RSD below 8% at the release pH endpoint.

If the same polymer is transferred to injectable formulations

In injectable applications, the product is not processed as a molecular solution but as a partially hydrated viscoelastic dispersion. Terminal sterilization by moist heat at 121 °C for 15 min is acceptable for a 1% w/v dispersion if the pH is clamped at 7.2 ± 0.2 with sodium hydroxide. Below pH 6.5, acid-catalysed hydrolysis can reduce viscosity by 12–18% per cycle and increase residual acrylic acid above the release limit. Sterile filtration through a 0.22 µm membrane is not recommended for dispersions above 0.5% w/v because the measured flow rate drops below 10 L/m²/h at 2.0 bar differential pressure on a polyethersulfone membrane. The injectable release specification adds bacterial endotoxin <0.25 EU/mg, total aerobic microbial count ≤10 CFU/g, and particulate matter requirements per USP <788> for large-volume parenterals.

Autoclave validation runs in a 1,000 L vented vessel with a 1% w/v dispersion showed a cold-spot F₀ of 15 min when the load configuration did not exceed 20 cm fill depth and the mixing agitator was operated at 20 rpm during heating and cooling. Deeper fill depths above 30 cm produced an F₀ differential of 6 min between top and bottom probes, which is not acceptable for parametric release. Osmolality of a 0.5% w/v dispersion after neutralization is 280–320 mOsm/kg when sodium chloride is used as tonicity adjuster; the residual sodium load from the polymer itself contributes 10–15 mOsm/kg, which is lower than fully neutralized sodium polyacrylate at equivalent concentration. The product is incompatible with amine-based buffers in aqueous form because residual carboxylic acid groups form ionic crosslinks with tromethamine at pH above 7.5, producing viscosity drift and possible precipitation. Polyvalent cations such as Ca²⁺ and Mg²⁺ can reduce viscosity through ionic bridging; this behaviour can be used for controlled gelation but concentration must be controlled within ±5% of target to avoid batch-to-batch variability.

Comparative performance against fully neutralized and non-neutralized polyacrylates

The principal distinction is hydration profile and ion load. Non-neutralized polyacrylic acid with a 0.5% w/v dispersion pH of 2.8–3.5 requires in situ neutralization during binder preparation; the resulting pH overshoot can exceed 9.0 at the impeller zone and produce viscosity gradients. Fully neutralized sodium polyacrylate with degree of neutralization above 95 mol% hydrates rapidly but is strongly hygroscopic, with moisture uptake of 15–25% w/w at 60% RH; this causes caking in feeder hoppers and makes direct compression impractical without continuous dry-air handling. PNP-PG-45 at 20–40 mol% neutralization shows moisture uptake of 8–12% w/w at 60% RH and disperses without a pre-neutralization step. In tablet formulations, non-neutralized polymer acts as a weak binder at low levels but retards disintegration above 10% w/w by gel formation; PNP-PG-45 at 5% w/w maintains disintegration below 15 min while providing hardness above 120 N. Fully neutralized polymer produces higher solution viscosity at 0.5% w/v (20,000–45,000 mPa·s) but reduces powder flow and increases sodium load, which is a limitation in injectable and low-sodium oral formulations.

Moisture uptake and terminal sterilisation boundaries

Equilibrium moisture content rises from 6% w/w at 40% RH to 12% w/w at 60% RH; above 75% RH, caking occurs within 24 h unless the product is packaged in double polyethylene bags with silica-gel desiccant. Storage at 25 °C ± 2 °C and 60% RH ± 5% RH according to ICH Q1A retains specification for 36 months. Pre-drying is required at relative humidity above 60% before any direct-compression campaign. In terminal autoclaving, nitrogen overlay is specified to maintain residual dissolved oxygen below 0.2 mg/L and to prevent oxidative chain scission. The product is incompatible with amine-based additives in aqueous systems and with high concentrations of polyvalent cations, as described above; these boundaries are stricter for injectable use because of particulate matter limits and viscosity drift.